A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 6 18-6, 1998, Pages

  Shetty, Sreerama ^a   Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Messenger ribonucleic acid binding protein

Indexed keywords

CELL SURFACE RECEPTOR; CYCLOHEXIMIDE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; RNA BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LUNG FIBROBLAST; MESOTHELIOMA; MESOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RABBIT; TISSUE DISTRIBUTION; TRANSCRIPTION REGULATION;

EID: 0031745225     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.6.l871     Document Type: Article

References (38)

1. Atwater, J. A., R. Wisdom, and I. M. Verma. Regulated mRNA stability. Annu. Rev. Genet. 24: 519-541, 1990.
2. Berstein, P., S. W. Peltz, and J. Ross. The poly-(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol. Cell. Biol. 9: 659-670, 1989.
3. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3′-untranslated region of lymphokine mRNA. Mol. Cell. Biol. 11: 3288-3295, 1991.
4. Bohjanen, P. R., B. Petryniak, C. H. June, C. B. Thompson, and T. Lindsten. AU RNA-binding factors differ in their binding specificities and affinities. J. Biol. Chem. 267: 6302-6309, 1992.
5. Cabrera, C. V., J. J. Lee, J. W. Ellison, R. J. Britten, and E. H. Davidson. Regulation of cytoplasmic mRNA prevalence in sea urchin enzymes - rates of appearance and turnover for specific sequences. J. Mol. Biol. 174: 85-111, 1984.
6. Carneiro, M., and U. Schibler. Accumulation of rare and moderately abundant mRNAs in mouse L-cells is mainly posttranscriptionally regulated. J. Mol. Biol. 178: 869-880, 1984.
7. Chen, F. Y., F. M. Amara, and J. A. Wright. Defining a novel ribonucleotide reductase R1 mRNA cis element that binds to a unique cytoplasmic trans-acting protein. Nucleic Acids Res. 22: 4796-4797, 1994.
8. Cohen, R. L., X. P. Xi, C. W. Cowley, B. K. Lucas, A. D. Levinson, and M. Shuman. Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells. Blood 78: 479-487, 1991.
9. Cubellis, M. V., M. L. Nolli, G. Cassani, and F. Blasi. Binding of single chain prourokinase to the urokinase receptor of human U937 cells. J. Biol. Chem. 261: 15819-15822, 1986.
10. Dano, K., P. A. Andreasen, J. Grondahl-Hansen, P. Kristensen, L. S. Nielsen, and L. Skriver. Plasminogen activators, tissue degradation and cancer. Adv. Cancer Res. 44: 139-266, 1985.
11. Diamond, D. J., and H. M. Goodman. Regulation of growth hormone messenger RNA synthesis by dexamethasone and triiodothyronine - transcriptional rate and mRNA stability changes in pituitary tumor cells. J. Mol. Biol. 181: 41-62, 1985.
12. Greenberg, M. E., and J. G. Belasco. Control of the decay of labile protooncogene and cytokine mRNAs. In: Control of Messenger RNA Stability, edited by J. Belasco and G. Brewerman. New York: Academic, 1993, p. 199-218.
13. Gyetko, M. R., R. F. Todd, C. C. Wilkinson, and R. G. Sitrin. The urokinase receptor is required for monocyte chemotaxis in vitro. J. Clin. Invest. 93: 1380-1387, 1994.
14. Howe, C. C., D. K. Lugg, and C. Overton. Posttranscriptional regulation of the abundance of mRNAs encoding alpha-tubulin and a 94,000-dalton protein in teratocarcinoma-derived stem cells versus differentiated cells. Mol. Cell. Biol. 4: 2428-2436, 1984.
15. Khalili, K., and R. Weinmann. Actin mRNAs in HeLa cells-stabilization and adenovirus infection. J. Mol. Biol. 180: 1007-1021, 1984.
16. Lee, W. M. F., F. C. Lin, and T. Curran. Activation of the transforming potential of the human fos protooncogene requires message stabilization and results in increased amounts of partially modified fos protein. Mol. Cell. Biol. 8: 5521-5527, 1988.
17. Levine, T. D., F. Gao, P. H. King, L. G. Andrew, and J. D. Keene. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNAs. Mol. Cell. Biol. 13: 3494-3504, 1993.
18. Lindsten, T., C. H. June, J.A. Ledbetter, G. Stella, and C. B. Thompson. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244: 339-342, 1989.
19. Lund, L. R., V. Ellis, E. Ronne, C. Pyke, and K. Dano. Transcriptional and posttranscriptional regulation of the receptor for urokinase-type plasminogen activator by cytokines and tumor promoters in the human lung carcinoma cell line A 549. Biochem. J. 310: 345-452, 1995.
20. Lund, L. R., E. Ronne, A. L. Roldan, N. Behrendt, J. Romer, F. Blasi, and K. Dano. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells. J. Biol. Chem. 263: 2358-2363, 1991.
21. Malter, J. S., and Y. Hong. Aredox switch and phosphorylation are involved in the posttranslational up-regulation of the adenosine-uridine binding factor by phorbol ester and ionophore. J. Biol. Chem. 266: 3167-3171, 1991.
22. Mattaj, I. W. RNA recognition: a family matter? Cell 73: 837-840, 1993.
23. Nakagawa, J., H. Waldner, S. M. Monard, J. Hofsteenge, P. Jeno, and C. Moroni. AUH, a gene encoding an AU-specific RNA binding protein with intrinsic enoyl-CoA hydratase activity. Proc. Natl. Acad. Sci. USA 92: 2051-2055, 1995.
24. Nielsen, L. S., G. M. Kellerman, N. Behrendt, R. Picone, K. Dano, and F. Blasi. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator-identification in human tumor cell lines and partial purification. J. Biol. Chem. 263: 2358-2363, 1988.
25. Picone, R., E. Kajtaniak, L. S. Nielsen, N. Behrendt, M. R. Mastroni-Cola, M. V. Cubellis, M. P. Stoppelli, S. Pedersen, K. Dano, and F. Blasi. Regulation of urokinase receptor in monocyte-like U937 cells by phorbol ester: phorbol myristate acetate. J. Cell Biol. 108: 693-702, 1989.
26. Raymond, V., J. A. Atwater, and I. M Verma. Removal of an mRNA destabilizing element correlates with the increased oncogenicity of protooncogene fos. Oncol. Res. 4: 861-865, 1989.
27. Sachs, A. B. Messenger mRNA degradation in eukaryotes. Cell 74: 413-421, 1993.
28. Saksela, O., and D. B. Rifkin. Cell associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4: 93-126, 1988.
29. Schuler, G. D., and M. D. Cole. GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55: 1115-1122, 1988.
30. Shaw, G., and R. Kamen. A conserved AU sequence from the 3′untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
31. Shetty, S., A. Kumar, and S. Idell. Posttranscriptional regulation of urokinase receptor mRNA: identification of a novel urokinase receptor mRNA binding protein in human mesothelioma cells. Mol. Cell. Biol. 17: 1075-1083, 1997.
32. Shetty, S., A. Kumar, A. R. Johnson, S. Pueblitz, D. Holiday, G. Raghu, and S. Idell. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am. J. Respir. Cell Mol. Biol. 15: 78-87, 1996.
33. Shetty, S., A. Kumar, A. R. Johnson, S. Pueblitz, and S. Idell. Urokinase receptor in malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am. J. Physiol. 268 (Lung Cell Mol. Physiol. 12): L972-L982, 1995.
34. Stephens, J. M.-B. Z. Carter, P. H. Pekala, and J. S. Malter. Tumor necrosis factor alpha-induced glucose transporter (GLUT-1) mRNA stabilization in 3T3-LI preadipocytes. Regulation by the adenosine-uridine binding factor. J. Biol. Chem. 267: 8336-8341, 1992.
35. Stoppelli, M. P., C. Tacchettti, M. V. Cubellis, A. Corti, V. J. Hearing, G. Cassani, E. Appella, and F. Blasi. Autocrine saturation of prourokinase receptors on human A431 cells. Cell 45: 675-684, 1986.
36. Vassalli, J.-D., A.-P. Sappino, and D. Belin. The plasminogen activator-plasmin system. J. Clin. Invest. 88: 1067-1072, 1991.
37. Zaidi, S. H. E., and J. S. Malter. Amyloid precursor protein mRNA stability is controlled by a 29-base element in the 3′ untranslated region. J. Biol. Chem. 269: 24007-24013, 1994.
38. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. Demaria, D. Crater, K. Dehaven, L. Long, and G. Brewer. Purification, characterization and cDNA cloning of a AU-rich element RNA binding protein, AUF1. Mol. Cell. Biol. 13: 7652-7665, 1993.